On this page · 5 sections
Search for the Cyprus IP Box and you will be offered a single rate, as if the relief were a sticker on any intellectual property a company happens to own. The statute does something narrower, and more useful once you can see it: an 80% deduction, available only on qualifying profit, and qualifying profit is set by a nexus fraction tied to research and development.
What the Cyprus IP Box actually is
The live regime is paragraph (κ) of section 9(1) of the Income Tax Law, which English notes render as section 9(1)(k). A person may deduct 80% of the qualifying profit from a qualifying intangible asset, and may waive all or part of that deduction in any year. Corporate tax, in the Second Schedule, is 15% on taxable profit. The Ministry of Finance describes the same relief in one line: 80% of the net profit, calculated under the nexus approach, on royalty income, embedded income and other qualifying income.
Two edges follow from that, and both are where published summaries go wrong.
First, the 80% is applied to qualifying profit, which is a defined product of a formula. It is not applied to turnover, and it is not applied to every euro of profit in the company.
Second, whatever remains in the tax computation is taxed at the ordinary corporate rate. There is no separate IP Box rate in the statute. If the nexus fraction is one, 80% of that asset's overall income is deducted and the balance stays in the computation at 15%. If the fraction is lower, less profit qualifies, more of it is taxed at 15%, and quoting the deduction on its own will overstate the relief.
The claimant has to be inside the Cyprus tax net. The 2016 regulations apply to a Cyprus tax resident, a permanent establishment in Cyprus of a non-resident, or a foreign permanent establishment that is taxed in Cyprus. The asset has to be acquired, developed or exploited in the course of a business. In practice the claimant is a company. A passive holding, with no business and no development spend, does not meet the regulations even if the intellectual property is valuable.
From 2026 a company incorporated in Cyprus is treated as tax resident unless a double tax treaty allocates residence elsewhere. Incorporation is the start of the analysis, not the relief. I cover the company side in Cyprus company formation.
The older IP regime in section 9(1)(e), which did extend to trademarks, expired on 30 June 2021 for the assets it still covered. It is not a fallback.
Which assets qualify — and which never do
Regulation 3 of KDP 336/2016 defines a qualifying intangible asset as intellectual property, other than marketing intellectual property, that results from research and development. Legal title is not essential: an asset of which the taxpayer has only economic ownership is included. The asset must still be the result of R&D, and the fraction below still applies.
What qualifies
- PatentsAs defined in the Patents Law
- Computer softwareNamed expressly, without the small-taxpayer certificate described below
- Utility models and certain rightsPlant-variety and genetic-material rights, orphan-drug designations, and extensions of patent protection, where they are legally protected
- Other novel assets, in a narrow caseNon-obvious, useful and novel assets, certified by a competent authority in Cyprus or abroad, and only where IP income stays within €7.5 million a year and group turnover within €50 million, on a five-year average
- The income, once the asset qualifiesRoyalties and other amounts for use, licence fees, insurance or compensation relating to the asset, trading profit on a disposal, and embedded income
What does not
- Brands, trade names and trademarksExcluded by the regulations, however valuable the brand
- Image rightsAnd other intellectual property used to market goods or services
- Goodwill and customer relationshipsMarketing intangibles, outside the R&D definition
- A finished asset you only boughtAcquisition cost is not qualifying expenditure, so the fraction collapses unless real further development follows
- The small-taxpayer bucket, if you are not smallThe certified "novel asset" category is unavailable once IP income or group turnover exceeds those averages. Patents and software do not depend on it
Embedded income is the item software companies actually live on. Where the asset sits inside a product, a service or a process you sell, the profit attributable to that asset can be qualifying income. It has to be traced to the asset. A single blended margin for the whole company is not a nexus calculation.
Overall income is not the gross royalty. The regulations define it as the income from the asset in the tax year, after direct costs of earning it. Those direct costs include the tax amortisation of capital expenditure on the asset under section 9(1)(l), which is spread over the asset's useful life up to a maximum of 20 years, including where the life is indefinite. The 80% deduction and that amortisation are different things. One writes off the cost. The other is a notional deduction on qualifying profit.
A disposal is easy to oversimplify. Overall income includes profit on a sale of the asset and excludes gains of a capital nature. Capital gains tax, including after the 2026 amendments, is aimed at immovable property in Cyprus and at shares that derive their value from it. Whether a particular sale of intellectual property is income or capital is a question of fact. A sale of the company's shares is a different analysis again, under the securities exemption, with those property edges. I will not tell you that an exit is untaxed. I will tell you which computation your facts fall into, and your tax advisor has to sign the characterisation.
How the nexus fraction is calculated
This is the part that decides the deduction, and it is the part a headline rate skips. Regulation 4 sets qualifying profit as:
The fraction is worked out for each asset, and the expenditure is cumulative over the life of that asset. A good year does not wash a weak history.
Qualifying expenditure is R&D incurred wholly and exclusively for the development, improvement or creation of that asset, and directly related to it. The regulations list, without limiting the list to these items: wages and salaries, direct costs, general expenses of facilities used for R&D, commissions related to R&D, and R&D outsourced to unrelated parties. It is included when it is incurred, whatever the accounting treatment.
It does not include the cost of acquiring the asset, interest, the cost of acquiring or constructing immovable property, amounts paid to a related party to carry out R&D (including under a cost-sharing arrangement), or costs you cannot show relate directly to a specific asset. R&D outsourced to unrelated parties, and general R&D costs that cannot be tied to one asset, may be apportioned across the assets or products they actually relate to.
Uplift expenditure is the lower of 30% of qualifying expenditure, and the sum of acquisition cost plus related-party R&D on that asset. Overall expenditure is qualifying expenditure plus that same acquisition cost and related-party R&D.
Read the "lower of" carefully, because the usual shorthand — multiply qualifying expenditure by 1.30, then cap the fraction at one — describes a different arithmetic. If you acquired nothing and outsourced nothing to a related party, the second limb is zero, so the uplift is zero. The fraction is one because you did the work, not because the regulations handed you a 30% bonus. The uplift exists to soften a modest amount of bought-in cost. It cannot exceed that bought-in cost, which is why the fraction never goes above one, and it cannot exceed 30% of the R&D that does qualify.
| Situation | Own R&D | Bought-in cost | Uplift | Fraction |
|---|---|---|---|---|
| All R&D in-house or with unrelated parties | 100 | 0 | 0 | 100% |
| Related-party R&D inside the 30% cap | 100 | 30 | 30 | 100% |
| Related-party R&D above the cap | 100 | 100 | 30 | 65% |
| Asset acquired, little further development | 10 | 90 | 3 | 13% |
Illustrative units, cumulative for a single asset. Bought-in cost means acquisition cost plus R&D outsourced to related parties. Qualifying profit is overall income multiplied by the fraction. Eighty per cent of that qualifying profit is the deduction. Taxable profit is charged at 15%.
A founder who pays an unrelated development team has qualifying expenditure. A founder who pays a group company for the same work has related-party cost in the denominator, helped by the uplift only up to the cap. Buying the finished asset from a parent, and doing little further development, is the bottom row. On those units the uplift is 3, overall expenditure is 100, and the fraction is 13%.
If the formula produces a loss rather than a profit, section 9(1)(k) limits the loss you may set off and carry forward to 20% of that loss. The deduction is not a way to manufacture a full loss out of a qualifying asset.
Where the relief stops
A few limits are structural. They are the reason I will not quote anyone an all-in burden from the IP Box alone.
The fraction can be small. Title, a licence agreement and a Cyprus company do not move it. Expenditure does.
Related-party dealings have a second set of rules. The price at which IP moves inside a group, and the price of related-party R&D, have to be supportable under Cyprus transfer pricing. A low acquisition price that is not arm's length is not a planning idea. It is an adjustment waiting to happen, and it still sits in the fraction as acquisition cost.
The R&D super-deduction does not stack on the same asset. For expenditure incurred from 2025 through 2030, section 9(1)(d) allows an additional deduction equal to 20% of qualifying R&D spend. That additional deduction is denied for expenditure on a qualifying asset once section 9(1)(k) has been applied to that asset in any year, including the current year. Choosing the IP Box is a choice. On that asset, you do not also take the extra 20%.
Other deductions stay in their own boxes. New equity may qualify for the notional interest deduction. The Ministry of Finance still describes it as it has stood since 2015: a deduction on new equity, capped at 80% of the taxable profit from the assets that equity finances. It is not part of the IP Box, and it is not a second bite at the same profit. Dividend treatment is a further, personal question — defence contribution depends on the shareholder — which I explain in the non-dom guide and in the 2026 tax reform. None of that changes the company's nexus fraction.
Large groups meet the global minimum tax. Cyprus transposed the EU directive with effect from 1 January 2024. A group with consolidated revenue of €750 million or more in at least two of the four preceding fiscal years is inside Council Directive (EU) 2022/2523. A top-up can apply even where the Cypriot computation has used the 80% deduction. If that is your group, the IP Box is a domestic rule, not a way under the minimum tax.
The benefit follows the asset's own history. Moving IP into Cyprus in year five does not rewrite years one to four. Later qualifying development improves the cumulative fraction from the date it is incurred. It does not re-label the acquisition.
The records that make or break the claim
Regulation 5 is one sentence, and it is the sentence that matters operationally. Anyone who claims the deduction must keep books and records of income and expenditure for each intangible asset.
That means, from the start of development: which people worked on which asset, which contractors were unrelated, which costs were shared and how you apportioned them, what was paid to related parties, and what the acquisition cost was. The fraction is not a percentage you elect in the return. It is a ratio those records either support or do not.
There is no advance clearance baked into the regime, which is why the records have to exist before anyone asks for them. The claim is made in the tax computation. If the records start in the year someone decides the rate looks attractive, the earlier expenditure cannot be rebuilt, and the fraction you can defend is the one your file supports.
If you want that file tested against a real asset — software, a patent, or something you hope is novel enough for the certified category — bring the ownership chain and the spend. I will tell you whether the regulations even reach it, and the tax advisor who prepares the computation can then work from facts rather than from a rate someone saw online.
Checked 10 November 2026. Primary texts: Income Tax Law of 2002, Law 118(I)/2002, as consolidated (section 9(1)(k) and (l), the R&D proviso in section 9(1)(d), and the Second Schedule corporate rate of 15%), via the CyLaw consolidation; Income Tax (Intangible Assets) Regulations of 2016, KDP 336/2016, regulations 3 to 6; Ministry of Finance, Tax Incentives (gov.cy, posted 15 January 2026), confirming the 80% nexus deduction on royalty, embedded and other qualifying income, and the separate notional interest deduction. Scope checks: PwC, Tax Facts & Figures 2026 — Cyprus (corporate rate, the modified nexus summary, capital gains confined to Cyprus immovable property and certain shares, and transposition of the EU global minimum tax from 1 January 2024); Council Directive (EU) 2022/2523, Article 2, for the €750 million threshold. EY, TaxLegi, 30 January 2026, for the 2026 company-residence and capital-gains amendments. This article is general information, not legal or tax advice. The fraction, transfer pricing and the return are matters for a licensed Cyprus tax advisor, whom I coordinate.